US Physical Therapy Q2 revenue up 17.3%

US Physical Therapy

06/08/2025 21:59

Overview

US Physical Therapy Q2 revenue from physical therapy operations rises 17.3% driven by record patient visits

Adjusted EBITDA for Q2 beats analyst expectations, rising 21.4% to $26.9 mln

Company raises full-year 2025 earnings guidance, reflecting strong performance

Outlook

Company raises full-year 2025 Adjusted EBITDA guidance to $93.0 mln-$97.0 mln

Company expects continued growth in injury prevention services

Result Drivers

RECORD PATIENT VISITS - US Physical Therapy reports all-time high of 1,558,756 patient visits in Q2 2025, a 16.7% increase from Q2 2024

CLINIC EXPANSION - Co added six clinics and acquired equity interests in new practices, contributing to revenue growth

IIP GROWTH - Industrial injury prevention services revenue rose 22.6% to $29.1 mln, driven by organic growth and acquisitions, per CEO Chris Reading

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 EPS
$0.58
Q2 Net Income
$12.40 mln
Q2 Adjusted EBITDA
Beat
$26.90 mln
$24.50 mln (7 Analysts)
Q2 Dividend
$0.45


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for US Physical Therapy Inc is $107.00, about 32.1% above its August 6 closing price of $72.69

The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 26 three months ago

Press Release: ID:nBw1jCcCSa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)